|MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B|
M Fabbri, R Garzon, A Cimmino, Z Liu, N Zanesi, E Callegari, S Liu, ...
Proceedings of the National Academy of Sciences 104 (40), 15805-15810, 2007
|Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock|
E Tili, JJ Michaille, A Cimino, S Costinean, CD Dumitru, B Adair, M Fabbri, ...
The Journal of Immunology 179 (8), 5082-5089, 2007
|Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice|
S Costinean, N Zanesi, Y Pekarsky, E Tili, S Volinia, N Heerema, ...
Proceedings of the National Academy of Sciences 103 (18), 7024-7029, 2006
|miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation|
M Garofalo, G Di Leva, G Romano, G Nuovo, SS Suh, A Ngankeu, ...
Cancer cell 16 (6), 498-509, 2009
|microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer|
C Braconi, T Kogure, N Valeri, N Huang, G Nuovo, S Costinean, ...
Oncogene 30 (47), 4750, 2011
|Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver|
S Hsu, B Wang, J Kota, J Yu, S Costinean, H Kutay, L Yu, S Bai, ...
The Journal of clinical investigation 122 (8), 2871-2883, 2012
|Reprogramming of miRNA networks in cancer and leukemia|
S Volinia, M Galasso, S Costinean, L Tagliavini, G Gamberoni, A Drusco, ...
Genome research 20 (5), 589-599, 2010
|Modulation of mismatch repair and genomic stability by miR-155|
N Valeri, P Gasparini, M Fabbri, C Braconi, A Veronese, F Lovat, B Adair, ...
Proceedings of the National Academy of Sciences 107 (15), 6982-6987, 2010
|Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice|
S Costinean, SK Sandhu, IM Pedersen, E Tili, R Trotta, D Perrotti, ...
Blood 114 (7), 1374-1382, 2009
|Targeted deletion of Wwox reveals a tumor suppressor function|
RI Aqeilan, F Trapasso, S Hussain, S Costinean, D Marshall, Y Pekarsky, ...
Proceedings of the National Academy of Sciences 104 (10), 3949-3954, 2007
|Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer|
E Tili, JJ Michaille, D Wernicke, H Alder, S Costinean, S Volinia, ...
Proceedings of the National Academy of Sciences 108 (12), 4908-4913, 2011
|Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression|
U Santanam, N Zanesi, A Efanov, S Costinean, A Palamarchuk, JP Hagan, ...
Proceedings of the National Academy of Sciences 107 (27), 12210-12215, 2010
|Karyotype-specific microRNA signature in chronic lymphocytic leukemia|
R Visone, LZ Rassenti, A Veronese, C Taccioli, S Costinean, BD Aguda, ...
Blood 114 (18), 3872-3879, 2009
|Regulation of cell size and contractile function by AKT in cardiomyocytes|
MVG Latronico, S Costinean, ML Lavitrano, C Peschle, G Condorelli
Annals of the New York Academy of Sciences 1015 (1), 250-260, 2004
|miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis|
KM Smith, M Guerau-de-Arellano, S Costinean, JL Williams, A Bottoni, ...
The Journal of Immunology 189 (4), 1567-1576, 2012
|miR-155 regulates IFN-γ production in natural killer cells|
R Trotta, L Chen, D Ciarlariello, S Josyula, C Mao, S Costinean, L Yu, ...
Blood 119 (15), 3478-3485, 2012
|MicroRNAs, the immune system and rheumatic disease|
E Tili, JJ Michaille, S Costinean, CM Croce
Nature Reviews Rheumatology 4 (10), 534, 2008
|Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation|
P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ...
Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014
|Regulation of acute graft-versus-host disease by microRNA-155|
P Ranganathan, CEA Heaphy, S Costinean, N Stauffer, C Na, ...
Blood 119 (20), 4786-4797, 2012
|miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eľ-miR-155 transgenic mouse model|
SK Sandhu, S Volinia, S Costinean, M Galasso, R Neinast, R Santhanam, ...
Proceedings of the National Academy of Sciences 109 (49), 20047-20052, 2012